Fabry Disease Clinical Trials

A listing of Fabry Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 33 clinical trials
A Study to Evaluate the Effect of Venglustat Tablets on Neuropathic and Abdominal Pain in Male and Female Adult Participants With Fabry Disease (PERIDOT)

disease in adult participants with Fabry disease who are treatment-naïve or untreated for at least 6 months. Study visits will take place approximately every 3 months. The double

neuropathic pain
abdominal pain
  • 33 views
  • 17 Jun, 2022
  • 3 locations
Study of the Effects of Fabrazyme Treatment on Lactation and Infants

The study will last for up to 2 years (24 months). Full participation for both mother and infant is 24 months, full participation of mother and development of infant is 24 months, while full participation of mother and no infant participation is 6 months

fabrazyme
agalsidase beta
  • 75 views
  • 26 May, 2022
  • 2 locations
Fabry Cardiomyopathy: Identification of Early Myocardial Structural and Tissue Abnormalities Using Multiparametric MRI (FIESTA-MRI)

This study will evaluate whether cardiac MRI T1 and T2 mapping improves our ability to detect early abnormalities in the heart in patients with Fabry disease and identify patients at increase

cardiomyopathy
  • 0 views
  • 05 Jun, 2022
  • 1 location
A Study to Evaluate the Effect of Venglustat Tablets on Neuropathic and Abdominal Pain in Male and Female Adult Participants With Fabry Disease (PERIDOT)

disease in adult participants with Fabry disease who are treatment-naïve or untreated for at least 6 months. Study visits will take place approximately every 3 months. The double

neuropathic pain
abdominal pain
  • 0 views
  • 30 Jun, 2022
  • 1 location
Canadian Fabry Disease Initiative (CFDI) National Registry (CFDI-NR)

CFDI NATIONAL REGISTRY Fabry disease is a rare, inherited, genetic condition due to a deficiency of an enzyme called alpha-galactosidase A. This enzyme deficiency causes

deficit
deficiency
neuropathic pain
genetic disorder
alpha-galactosidase
  • 149 views
  • 23 Jan, 2022
  • 5 locations
Fabry Disease Registry & Pregnancy Sub-registry

The Fabry Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Fabry disease, irrespective of treatment

replacement therapy
deficiency
alpha-galactosidase
deficit
fabrazyme
  • 2 views
  • 24 Jun, 2022
  • 251 locations
Fabry Disease Registry & Pregnancy Sub-registry

The Fabry Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Fabry disease, irrespective of treatment

replacement therapy
deficiency
alpha-galactosidase
deficit
fabrazyme
  • 460 views
  • 11 Jul, 2022
  • 251 locations
Screening of Fabry Disease in Portuguese Patients With Idiopathic Cardiomyopathies (F-CHECK)

In Portugal, the prevalence of Fabry disease is largely unknown as recently has been stressed by the Portuguese hypertrophic cardiomyopathy registry investigators. On the other hand, few

  • 0 views
  • 13 Jun, 2022
  • 1 location
Evaluation of HEArt invoLvement in Patients With FABRY Disease (HEAL-FABRY)

This study evaluates predictors for the incidence of arrhythmias and sudden cardiac death as well as terminal heart failure in patients with Fabry disease.

sudden cardiac death
heart failure
arrhythmia
  • 20 views
  • 27 Jul, 2022
  • 3 locations
Epidemiological Study of Fabry Disease Screening in Chronic Kidney Disease Patients

Fabry disease is a rare X-linked lysosomal storage disorder caused by deficient activity of the enzyme -Gal A resulting from mutations affecting the GLA gene. It is characterized by

deficiency
globotriaosylceramide
renal function
gla gene
deficit
  • 0 views
  • 29 Sep, 2021
  • 1 location